Ovarian Cancer Canada is investing in six Manitoba-based research projects thanks to a $1 million commitment from the Province of Manitoba.

Drs. Jamieson and McAlpine are exploring precision treatment to reduce unnecessary side effects for patients with ovarian and endometrial cancer.

Ovarian Cancer Awareness Month is deeply personal for me. I was diagnosed with ovarian cancer in 2018, but at the time, cancer was the last thing on my mind.

Navigating survivorship. Join us for honest conversations, expert insights and real-world perspectives on life after gynecological cancer treatment.

Before a breakthrough can be uncovered in a research lab, it usually begins with collaboration in a conference room. Here’s what we heard and saw at the Canadian Conference on Ovarian Cancer Research

After years of advocacy, patients with platinum-resistant ovarian cancer are still waiting for access to a treatment approved by Health Canada and recommended for reimbursement.

Ovarian Cancer Canada and the Cancer Research Society (CRS) are investing $200,000 in two new patient-centered research projects to improve treatment and prevention strategies for Canadians affected by ovarian and endometrial cancers.

Patient engagement is improving ovarian and endometrial cancer research in Canada by helping scientists design more effective, accessible care solutions.

We are deeply disappointed by this outcome and stand with patients with ovarian cancer as they face the loss of access to a critically needed treatment option.